Back to The PMRExam Podcast

Podcast Episode

Contrast Agents and Corticosteroid Selection for Pain Management Injections

The PMRExam PodcastΒ·Β·29 April 2026Β·17 min

About this episode

πŸŽ™οΈ PainExam Podcast Show Notes Corticosteroids & Contrast Agents in Pain Management + Evidence-Based Steroid Selection πŸ”₯ Episode Overview In this high-yield episode of the PainExam Podcast, David Rosenblum breaks down a must-know board topic: πŸ‘‰ Injectable corticosteroids vs contrast agents in interventional pain procedures This episode goes beyond basics and dives into: Particulate vs non-particulate steroids Comparative profiles of dexamethasone, betamethasone, triamcinolone, and methylprednisolone Contrast agent selection and safety Critical complications including embolization and neurotoxicity A recent study comparing steroid effectiveness in transforaminal epidural injections This is essential for physicians preparing for the ABA Pain Medicine boards and for clinicians performing spine interventions. 🧠 Core Concept Corticosteroids = therapeutic (reduce inflammation) Contrast agents = diagnostic + safety tools (confirm needle placement) πŸ‘‰ Board pearl: Steroids treat pain β€” contrast prevents complications πŸ’‰ Corticosteroids β€” High-Yield Comparison πŸ”¬ Mechanism Inhibit phospholipase A2 Reduce inflammatory mediators Decrease nerve root irritation βš–οΈ Key Steroids Compared Steroid Type Particle Profile Key Advantage Major Risk Dexamethasone Non-particulate No aggregation Safest for TFESI Possibly shorter duration Triamcinolone Particulate Large particles Longer depot effect Embolic infarction Methylprednisolone Particulate Aggregates Strong anti-inflammatory Avoid in cervical TFESI Betamethasone Mixed Depends on formulation Potent Acetate = particulate risk 🚨 Major Steroid Risks Local: Tissue atrophy Depigmentation Systemic: Hyperglycemia Adrenal suppression Immunosuppression Catastrophic (Board Tested): Spinal cord infarction Stroke πŸ‘‰ Caused by intra-arterial injection of particulate steroids πŸ“Š Contrast Agents β€” High-Yield Review Common Agents Iohexol (Omnipaque) Iopamidol (Isovue) Iodixanol (Visipaque) 🎯 Purpose Confirm needle placement Detect intravascular injection Prevent intrathecal injection ⚠️ Risks Allergic reaction Anaphylaxis Contrast-induced nephropathy πŸ‘‰ Board pearl: Shellfish allergy β‰  contrast allergy ⚠️ Critical Safety Topic: Gadolinium Gadolinium-based contrast agents are: ❌ NOT approved for epidural or intrathecal use ❌ NOT safe substitutes for iodinated contrast in spine procedures 🚨 Intrathecal Gadolinium Risks Encephalopathy Seizures Respiratory distress Death πŸ‘‰ Extremely high-yield board concept πŸ“š Evidence-Based Medicine Segment Study Review: Steroid Selection in TFESI A recent study comparing: Dexamethasone Methylprednisolone Betamethasone πŸ”‘ Key Findings Dexamethasone showed comparable or better outcomes No clear advantage of particulate steroids Similar rates of: Repeat injections Surgical progression 🎯 Clinical Implication πŸ‘‰ Efficacy differences are smaller than previously thought πŸ‘‰ Safety is driving practice change 🚨 Board-Level Takeaway Non-particulate steroids = safer Outcomes β‰ˆ similar Technique matters more than steroid choice πŸ‘‰ Best exam answer: dexamethasone for TFESI 🎯 Board Prep Summary Dexamethasone = safest for transforaminal injections Particulate steroids = embolic risk Contrast must be used before steroid injection Gadolinium = dangerous in neuraxial space Clinical outcomes often similar across steroid types πŸŽ“ Pain Board Prep Resources Prepare for your ABA Pain Medicine boards with: πŸ‘‰ https://painexam.com πŸ‘‰ https://nrappain.org πŸ† Why Physicians Choose NRAP Academy High-yield board review content Thousands of MCQs Virtual Pain Fellowship Ultrasound + regenerative training Real-world clinical integration Register Today! 🎀 Upcoming Training Ultrasound-guided pain procedures Regene